Close Menu

NEW YORK (GenomeWeb) – Becton Dickinson announced today that it has received approval from the US Food and Drug Administration for its BD Max Vaginal Panel for the diagnosis of vaginitis and vaginosis in women who exhibit symptoms of vaginal infections. 

The assay runs on the BD Max System, which combines automated real-time PCR extraction, amplification, and detection on a single platform. It is designed to detect the pathogens responsible for bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.